Clin Mol Hepatol > Volume 23(4); 2017 > Article |
|
Intrahepatic tumor |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Published | Characteristics | Etiology | Metastasized to | Max diameter (cm) | Initial dose (mg/day) | Time to CR (mon) | Time to cessation (mon) | Histologic CR | Initial AFP (ng/mL) | PVTT | F/u period (mon) | Bx. at diagnosis | Child-Pugh class | HFSR | HCC related treatment |
So et al. [9] (2008) | 78, M, USA | HHC | Lung | Multiple | 800 | 5 | 6 | NA | 13,599 | Unknown | 6 | diagnosis | Pugh | No | - |
5.0 | class | ||||||||||||||
Yeganeh et al. [10] (2009) | 54, M, USA (Asian) | HBV | Lung (4.1 cm) | No | 800 | 18 | Maintain | NA | 1.3 | No | Unknown | No | Unknown | Yes | RFA, TACE, OLT, Adjuvant chemotherapy |
- | |||||||||||||||
Wang et al. [11] (2010) | 74, M, USA | HCV | - | Single | 400 | 8 | 8 | NA | 3300 | Yes | 19 | No | A | Unknown | - |
10 | |||||||||||||||
Kudo et al. [12] (2010) | 68, M, Japan | HBV | Lung | Single | 800 | 2 | Unknown | NA | 18,775 | Invasion to | >1 year | No | A | Unknown | TACE |
Unknown | IVC | ||||||||||||||
Kudo et al. [12] (2010) | 68, M, Japan | HBV | Lung, lymph node, adrenal gland | Multiple | 400 | 6 | Maintain | NA (Metastatic lesion) | 10,559 | Yes | >1 year | No | A | Unknown | TACE, Hepatectomy, HAIC |
Unknown | |||||||||||||||
Chelis et al. [13] (2011) | 69, M, Greece | HBV+HIV | Lymph node | Single | 400 | 6 | Unknown | NA | W.N.L | Unknown | 10 | Yes | Unknown | Yes | TACE HARRT |
5.2 | |||||||||||||||
Sacco et al. [14] (2011) | 84, M, Italy | HCV | - | Single | 800 | 6 | Maintain | NA | 353 | Yes | 12 | No | A | No | - |
6.0 | |||||||||||||||
Curtit etal. [15] (2011) | 56, M, France | HCV | Diaphragm, IVC | Multiple | 800 | 6 | 6 | Yes | 3,315 | No | 6 | No | A | Yes | Surgical resection |
15 | |||||||||||||||
Irtan et al. [16] (2011) | 59, M, France | HHC | Lymph node, omentum | Single | 800 | 6 | 6 | Yes | 效 6 | Yes | 16 | No | A | Yes | Surgical resection |
10 | |||||||||||||||
Irtan et al. [16] (2011) | 57, M, France | HBV | - | Single | 800 | 12 | 12 | Yes | 17,000 | Yes | 12 | No | A | No | Surgical resection |
8 | |||||||||||||||
Inuzuka et al. [8] (2011) | 76, F, Japan | HCV | Lung (>60) | No | 400 | 4 | 4 | NA | 6,952 | No | 8 | No | A | No | PEI, TACE, RFA |
- | |||||||||||||||
Mizukami et al. [17](2012) | 69, M, Japan | HCV | Lymph node | No | 800 | 0.4 | 0.4 | NA | 25.1 | No | 10 | No | A | Yes | - |
- | |||||||||||||||
Kim et al. [18] (2013) | 66, M, Korea | Alcoholic | Lymph node | Multiple | 800 | 3 | 12 | NA | 2,795 | Yes | 8 | No | A | Unknown | TACE, HAIC |
LC | Unknown | ||||||||||||||
Kermiche-Rahali et al. [19] (2013) | 68, M, France | Alcoholic | - | Single | 800 | 10 | 9 | Yes | 9效 | No | 14 | No | A | Yes | Surgical resection |
LC | 15.7 | ||||||||||||||
Moroni et al. [20] (2013) | 78, M, Italy | HCV | - | Single | 800 | 22 | 22 | NA | 58,560 | Yes | 26 | Yes | A | Yes | |
9.0 |
AFP, alpha-fetoprotein; CR, complete response; PVTT, portal vein tumor thrombosis; HFSR, hand-foot skin reaction; HCC, hepatocellular carcinoma; HHC, hereditary hemochromatosis;; HBV, hepatitis B virus; HCV, HCV, hepatitis C virus; HIV, human immunodeficiency virus; LC, liver cirrhosis; IVC, inferior vena cava; RFA, radiofrequency ablation; TACE, transarterial chemoembolization; PEI, percutaneous ethanol injection; OLT, orthotopic liver transplantation; HAIC, hepatic arterial infusion chemotherapy; HAART, Highly Active Antiretroviral Therapy; NA, Not available.
Ji Hoon Kim
https://orcid.org/0000-0003-3924-0434